v3.26.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Investments at amortized cost $ 3,324,332 [1],[2],[3] $ 3,323,282 [4],[5],[6]
Restricted cash 28,072 16,727
Deferred financing costs $ 22,693 $ 24,411
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common shares, par value $ 0.01 $ 0.01
Common shares, authorized 400,000,000 400,000,000
Common shares, issued 95,683,850 95,369,400
Common shares, outstanding 95,019,600 94,705,150
Treasury stock, shares 664,250 664,250
Non-controlled, Non-affiliated Investments    
Investments at amortized cost $ 3,228,777 $ 3,244,762
Non-controlled, Affiliated Investments    
Investments at amortized cost 14,665 0
Controlled, Affiliated Investments    
Investments at amortized cost $ 80,890 $ 78,520
[1] As of March 31, 2026, the estimated cost basis of investments for U.S. federal tax purposes was $3,334,261 resulting in estimated gross unrealized gains and losses of $243,959 and $283,761, respectively.
[2] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
[3] Unless otherwise indicated, the Company’s portfolio companies are domiciled in the United States. Certain portfolio company investments are subject to contractual restrictions on sales.
[4] As of December 31, 2025, the estimated cost basis of investments for U.S. federal tax purposes was $3,332,367 resulting in estimated gross unrealized gains and losses of $219,540 and $231,975, respectively.
[5] Certain portfolio company investments are subject to contractual restrictions on sales.
[6] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.